Biocorp Production SAS - Dose Control System for Injectable-Drug Delivery Devices (EP3573687A1)
Summary
The European Patent Office published patent application EP3573687A1 for Biocorp Production S.A.S., covering a dose control system for injectable-drug delivery devices and associated methods of use. The patent application (filed under IPC classifications A61M 5/20 and A61M 5/315) was published April 8, 2026. The application designates all EU member states and extended states including Switzerland, Norway, and Turkey.
What changed
The EPO published patent application EP3573687A1 for Biocorp Production S.A.S., covering a dose control system for injectable-drug delivery devices. This grant establishes enforceable intellectual property rights in the designated contracting states, giving the patent holder exclusive rights to the claimed invention.
Medical device manufacturers developing similar dose-controlled injection systems should conduct freedom-to-operate analyses to assess potential infringement risks. Competitors may need to design around the patent claims or seek licensing arrangements with the patent holder.
What to do next
- Monitor for updates
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
DOSE CONTROL SYSTEM FOR INJECTABLE-DRUG DELIVERY DEVICES AND ASSOCIATED METHODS OF USE
Publication EP3573687A1 Kind: A1 Apr 08, 2026
Applicants
Biocorp Production S.A.S.
Inventors
ALDON, Lionel, MARCOZ, Alain
IPC Classifications
A61M 5/20 20060101AFI20180803BHEP A61M 5/315 20060101ALI20180803BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.